NHS vs private mole removal a frank comparison

The NHS uses a structured pathway called the two-week-wait (2WW) referral for suspected skin cancers. A GP who sees a lesion meeting specific criteria can refer the patient to NHS dermatology with a guarantee of being seen within 14 days. Once seen, suspicious lesions are biopsied or excised promptly, and any cancer diagnosis enters a defined cancer-treatment pathway with target timelines (62 days from referral to treatment).^[1]

The 2WW criteria reflect the features dermatologists associate with melanoma and aggressive non-melanoma skin cancer. They include: a mole that has changed in size, shape or colour; a new mole appearing in an adult that doesn't look like surrounding moles; a lesion that itches, bleeds or crusts persistently; any pigmented lesion with a 7-point checklist score above threshold; or a non-healing skin lesion that's enlarging. A GP applying the criteria correctly captures the great majority of melanomas before they progress.

If your lesion meets 2WW criteria and your GP refers you, the NHS pathway is excellent. You will be seen by a consultant dermatologist within two weeks at no cost, with appropriate further investigation arranged the same day where indicated. Anyone with a clinically suspicious mole should have this conversation with their GP first; private is not a substitute for an urgent NHS pathway when 2WW criteria apply.

The NHS works well at the two-week-wait end and at confirmed cancer treatment; it works less well in the middle. The middle is the patient who has a mole they're worried about, but their GP doesn't think it meets 2WW criteria and refers as a routine dermatology appointment instead. Routine NHS dermatology waits in 2026 vary regionally from about 12 weeks to over 26 weeks for a first consultant appointment.^[2] Months can pass before a non-urgent lesion is even examined, and any subsequent procedure adds further wait.

For a lesion that turns out to be benign, the wait is just inconvenience and worry. For a lesion that's borderline or that progresses while waiting, the wait can have clinical consequences. This is the gap private clinics fill: same-week consultant assessment with dermatoscopy, same-day excision where appropriate, and histology results within 7-10 working days. The fee buys you compressed time more than better medicine.

A practical heuristic. If your lesion is genuinely worrying you and your GP isn't fast-tracking it via 2WW, the question becomes: how many months of low-grade anxiety are you prepared to pay to avoid £250-£475? Many patients reach for the private appointment specifically because the anxiety is worse than the cost, and find the resulting reassurance worth it. Others rationally choose to wait, particularly if the lesion clearly looks benign.

NHS England, Scotland, Wales and Northern Ireland all classify cosmetic mole removal as a procedure of limited clinical value under their commissioning frameworks.^[3] In practical terms, this means NHS-funded removal is restricted to lesions where there is genuine diagnostic uncertainty, suspected malignancy, or significant functional impact (a mole that catches on clothing repeatedly, bleeds with normal activities, or interferes with vision/eating).

If a mole is bothering you for purely cosmetic reasons, the NHS will not pay to remove it. Your GP can refer you, but the dermatologist will assess whether the lesion meets the local commissioning policy, and most cosmetic-only requests are declined. This is not a flaw in the NHS; it is a deliberate prioritisation of finite resources toward clinically necessary care. It also means the only available route for cosmetic mole removal in the UK is private, which is where the £200-£700 range we discussed elsewhere lives.

The grey zone is the mole that's both cosmetically annoying and medically borderline (it's caught on clothing, but also has a slightly irregular border on dermatoscopy). In those cases, the NHS may fund excision with histology specifically to rule out malignancy; the cosmetic improvement is a side effect. Whether your lesion qualifies depends on your GP's judgment and local commissioning policy.

Three scenarios where private mole removal is the rational choice, even for patients who use the NHS for everything else.

Cosmetic-only removal. The NHS won't do it; private is your only option. Pricing across the UK ranges from about £275 to £700 depending on lesion and location. We charge £275 first lesion, £175 each additional lesion, with optional £100 cosmetic consultation deducted from the procedure fee. Speed for non-urgent worry. A lesion that's bothering you but not 2WW-meeting can wait months on NHS routine dermatology. Private compresses that to days, with the same consultant calibre. The fee is the value of your time and peace of mind. Definitive diagnosis you control. If you want histology on a specific lesion that the NHS would either not refer or assess as below threshold, private gets you the answer faster and on your timeline.

Three scenarios where private is not the better option. 2WW-meeting lesions where your GP is referring you. Use NHS, the pathway is excellent and free. Confirmed melanoma management. NHS multidisciplinary teams plus oncology coordination outperforms most private alternatives. Routine annual screening for low-risk patients. A mole check every 2-3 years at £250 is reasonable; for genuinely low-risk patients, it may be more cost-effective to wait and only spend money when there's a specific concern.

The clinical content of an NHS consultant dermatology appointment and a private consultant dermatology appointment is, fundamentally, the same. The same training, the same dermatoscopy, the same evidence base. Many of the consultants you'd see privately also run NHS clinics; they bring identical expertise to both settings.

What the private fee adds is logistics and experience: faster booking, longer appointment slots (30 minutes vs 10-15), a fixed point of contact if you have follow-up questions, a written report within 24 hours, and same-day procedure where indicated. The clinical decision-making is not better; the experience around it is.

Two specific examples of where the experience matters in practice. First, dermatoscopy: a 30-minute private appointment lets the consultant scan the entire skin surface and surface unexpected lesions, where a 10-minute NHS slot is constrained to the referred lesion only. Second, post-procedure communication: a private clinic typically gives you the consultant's direct email or a clinic line that's answered the same day, where NHS post-discharge queries route through GP or letter. Neither difference changes the medicine; both shape the experience.

Walk through these three questions in order. Does the lesion meet two-week-wait criteria (changing, new in adulthood, itching/bleeding, multi-coloured)? If yes, see your GP for an urgent NHS referral. Private is unnecessary; NHS is excellent at this end. Is the lesion purely cosmetic (you've decided you want it gone, not assessed)? If yes, private is your only option in the UK. Compare published self-pay fees against insurance-led private quotes (the self-pay route is usually cheaper or break-even).

Is the lesion in the middle (worrying you but not 2WW; bothering you but not cosmetic-only)? This is the judgement call. Three sub-questions help. How long can you tolerate waiting (NHS routine: 12-26 weeks; private: under a week)? How meaningful is the cost (£250-£475 for assessment with potential excision and histology)? Does your specific GP think it warrants a 2WW upgrade or remain at routine? If the answer to the last is 'routine', and you'd rather not wait months, private is reasonable.

Most of the patients who book a private skin cancer check at our clinic fall into the third category: lesions that don't quite meet 2WW criteria but are bothering them enough that waiting feels worse than paying. The majority leave reassured, the minority who need treatment have it within two weeks of first contact, and the whole process happens on their timeline rather than the NHS routine queue's.

Patients sometimes worry that going private for a worrying mole means losing access to the NHS pathway if cancer is found. This is not how it works. A private consultant who diagnoses melanoma or another skin cancer routinely refers the patient back into NHS specialist services for definitive management, with all the imaging, multidisciplinary review and follow-up that involves. The private clinic's role is the diagnosis and (where appropriate) the initial excision; the cancer treatment pathway flows through NHS oncology services thereafter.

We coordinate this transition warmly. Your histology report goes to your GP and to the relevant NHS specialty team, with a referral letter that flags urgency where appropriate. You enter the NHS cancer pathway at the same priority level as if you'd come through 2WW, often faster because the diagnosis is already made and the staging is partly established. Some patients elect to continue ongoing surveillance privately (annual mole mapping, scar reviews); others move entirely to NHS follow-up. Both are reasonable.

The key practical point: getting a private diagnosis does not exclude you from NHS treatment. The two systems coexist by design, and consultants who work in both move patients between them routinely. You should not feel obliged to stay private once a diagnosis crystallises into a complex treatment plan.